Serial 98160020
Live / Applied — Second extension granted (statement of use) (as of 09 Oct 2025)
What this means for you
Not registered yet, but its 31 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98160020
- Mark type
- Design / logo
- Filed
- 31 Aug 2023
- Published for opposition
- 27 Aug 2024
- Attorney of record
- Susan Piascik Christoff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations all for use in the prevention and treatment of ophthalmological, immunological, and inflammatory diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; scientific and medical research services in the field of pharmaceutical development; scientific and medical information services in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals
Owner
- Iolyx Therapeutics, Inc., Burlingame, CA, US
- Iolyx Therapeutics, Inc., Burlingame, CA, US
Prosecution history
- 10 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Oct 2025 — SOU EXTENSION 2 GRANTED
- 09 Oct 2025 — SOU EXTENSION 2 FILED
- 09 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Apr 2025 — SOU EXTENSION 1 GRANTED
- 14 Apr 2025 — SOU EXTENSION 1 FILED
- 14 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Aug 2024 — PUBLISHED FOR OPPOSITION
- 19 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Aug 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Aug 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED